CORR Insights®: Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry.
作者信息
Koo Kyung-Hoi
机构信息
K. Koo, Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam, South Korea.
出版信息
Clin Orthop Relat Res. 2019 Jun;477(6):1344-1346. doi: 10.1097/CORR.0000000000000749.
Abstract
摘要
相似文献
1
CORR Insights®: Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry.CORR见解®：新型口服抗凝剂用于髋关节置换手术的术后血栓预防优于低分子肝素：来自瑞典注册研究的结果。
Clin Orthop Relat Res. 2019 Jun;477(6):1344-1346. doi: 10.1097/CORR.0000000000000749.
2
Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry.新型口服抗凝剂在髋关节置换手术中的术后血栓预防优于低分子肝素：来自瑞典登记处的研究结果。
Clin Orthop Relat Res. 2019 Jun;477(6):1335-1343. doi: 10.1097/CORR.0000000000000714.
3
Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.低分子量肝素或利伐沙班预防髋膝关节置换术后血栓栓塞的疗效和安全性：来自 ORTHO-TEP 注册研究的结果。
Thromb Haemost. 2013 Jan;109(1):154-63. doi: 10.1160/TH12-07-0510. Epub 2012 Nov 29.
4
Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.新型口服抗凝剂与标准抗血栓预防治疗在全髋关节或膝关节置换患者中的比较效果：系统评价。
Ann Intern Med. 2013 Aug 20;159(4):275-84. doi: 10.7326/0003-4819-159-4-201308200-00008.
5
Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.Xa 因子抑制剂和直接凝血酶抑制剂与低分子肝素在全髋关节或全膝关节置换术后预防血栓形成的比较：系统评价和荟萃分析。
J Arthroplasty. 2019 Apr;34(4):789-800.e6. doi: 10.1016/j.arth.2018.11.029. Epub 2018 Dec 1.
6
Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.低分子量肝素与手术部位出血并发症的相对风险：全关节置换术后患者静脉血栓预防随机对照试验的系统评价和荟萃分析结果
J Arthroplasty. 2017 Sep;32(9):2911-2919.e6. doi: 10.1016/j.arth.2017.04.010. Epub 2017 Apr 14.
7
Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.阿司匹林作为初次全髋关节和膝关节置换术多模式抗栓治疗的临床疗效：6078 例病例回顾。
J Arthroplasty. 2019 Jul;34(7):1359-1363. doi: 10.1016/j.arth.2019.03.021. Epub 2019 Mar 13.
8
The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.阿司匹林和低分子量肝素对髋关节置换术后静脉血栓栓塞的影响：来自国家关节注册中心信息的非随机比较
J Bone Joint Surg Br. 2011 Nov;93(11):1465-70. doi: 10.1302/0301-620X.93B11.27622.
9
Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.直接口服抗凝剂与低分子肝素预防全髋关节或膝关节置换术后静脉血栓栓塞症的效果比较：一项全国性数据库队列研究。
Pharmacol Res. 2019 Mar;141:201-207. doi: 10.1016/j.phrs.2018.12.018. Epub 2018 Dec 21.
10
Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.低分子量肝素与其他抗血栓药物用于预防全髋关节或全膝关节置换术后静脉血栓栓塞事件：一项系统评价和荟萃分析。
BMC Musculoskelet Disord. 2018 Sep 8;19(1):322. doi: 10.1186/s12891-018-2215-3.
引用本文的文献
1
Comparison between low molecular weight heparin and apixaban (direct oral anticoagulant) in the prophylaxis against venous thromboembolism after laparoscopic sleeve gastrectomy.低分子量肝素与阿哌沙班（直接口服抗凝剂）在预防腹腔镜袖状胃切除术后静脉血栓栓塞方面的比较。
Obes Surg. 2025 Mar;35(3):934-940. doi: 10.1007/s11695-025-07721-y. Epub 2025 Feb 8.
本文引用的文献
1
Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry.新型口服抗凝剂在髋关节置换手术中的术后血栓预防优于低分子肝素：来自瑞典登记处的研究结果。
Clin Orthop Relat Res. 2019 Jun;477(6):1335-1343. doi: 10.1097/CORR.0000000000000714.
2
Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty.髋关节和膝关节置换术后预防静脉血栓栓塞的抗凝剂的比较疗效和安全性。
Acta Orthop. 2017 Dec;88(6):634-641. doi: 10.1080/17453674.2017.1361131. Epub 2017 Aug 8.
3
Atypical subtrochanteric fractures in Korean hip fracture study.韩国髋部骨折研究中的非典型转子下骨折。
Osteoporos Int. 2017 Oct;28(10):2853-2858. doi: 10.1007/s00198-017-4112-2. Epub 2017 Jun 14.
4
Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis.低剂量阿司匹林对全关节置换术后具有临床重要意义的静脉血栓栓塞有效：一项初步分析。
J Bone Joint Surg Am. 2017 Jan 18;99(2):91-98. doi: 10.2106/JBJS.16.00147.
5
Preventing Venous Thromboembolism with Use of Intermittent Pneumatic Compression after Total Hip Arthroplasty in Korean Patients.韩国患者全髋关节置换术后使用间歇性充气加压预防静脉血栓栓塞
J Korean Med Sci. 2016 Aug;31(8):1319-23. doi: 10.3346/jkms.2016.31.8.1319. Epub 2016 May 24.
6
Venous Thromboembolism Following Hip and Knee Replacement Arthroplasty in Korea: A Nationwide Study Based on Claims Registry.韩国髋膝关节置换术后静脉血栓栓塞症：一项基于理赔登记的全国性研究
J Korean Med Sci. 2016 Jan;31(1):80-8. doi: 10.3346/jkms.2016.31.1.80. Epub 2015 Dec 24.
7
Network Meta-analysis: Users' Guide for Surgeons: Part II - Certainty.网状Meta分析：外科医生用户指南：第二部分 - 确定性
Clin Orthop Relat Res. 2015 Jul;473(7):2172-8. doi: 10.1007/s11999-015-4287-9. Epub 2015 Apr 14.
8
Network Meta-analysis: Users' Guide for Surgeons: Part I - Credibility.网状Meta分析：外科医生用户指南：第一部分 - 可信度
Clin Orthop Relat Res. 2015 Jul;473(7):2166-71. doi: 10.1007/s11999-015-4286-x. Epub 2015 Apr 14.
9
Deep venous thrombosis and pulmonary embolism are uncommon in East Asian patients after total hip arthroplasty.在东亚患者中，全髋关节置换术后深静脉血栓形成和肺栓塞并不常见。
Clin Orthop Relat Res. 2011 Dec;469(12):3423-8. doi: 10.1007/s11999-011-1979-7. Epub 2011 Jul 12.
10
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.开展间接治疗比较和网络荟萃分析研究：ISPOR 间接治疗比较良好实践工作组报告：第 2 部分。
Value Health. 2011 Jun;14(4):429-37. doi: 10.1016/j.jval.2011.01.011.
Zotero 插件